Clinical Report: National Institutes of Health Builds Digital Model of RPE Cells

Overview

Researchers at the NIH have developed a 3D digital model of retinal pigment epithelium (RPE) cells, derived from induced pluripotent stem cells, to study changes in cellular organization associated with age-related macular degeneration (AMD). This model utilizes AI to analyze cellular structures and may aid in therapeutic discovery.

Background

Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults, making the understanding of RPE cell organization crucial for developing effective treatments. RPE cells play a vital role in recycling photoreceptor outer segments and managing nutrient and waste exchange. The ability to model RPE cells digitally allows researchers to investigate the cellular mechanisms underlying AMD and other diseases. This innovative approach combines artificial intelligence with biological modeling to enhance our understanding of cellular processes.

Data Highlights

The model is based on 3D imaging data from approximately 1.3 million induced pluripotent stem cell-derived RPE cells collected across nearly 4,000 fields of view.

Key Findings

• The digital twin of RPE cells provides a platform to study cellular organization changes in AMD.
• AI algorithm POLARIS (Polarity Organization with Learning-based Analysis for RPE Image Segmentation) was trained to identify nuclei, mitochondria, and cytoskeletal structures at subcellular resolution.
• Healthy RPE cells follow a predictable trajectory toward polarization, which is disrupted in AMD.
• The atlas distinguishes between polarized and nonpolarized states of RPE cells.
• This technology may support therapeutic discovery for AMD and other diseases involving loss of cellular organization.

Clinical Implications

The development of a digital model for RPE cells offers a new avenue for understanding AMD and may facilitate the discovery of novel therapeutic strategies. Clinicians may benefit from insights gained through this model, potentially leading to improved patient care in AMD management. This model could also be adapted for other diseases involving cellular organization loss.

Conclusion

The creation of a 3D digital model of RPE cells represents a significant advancement in AMD research, providing a valuable tool for exploring cellular dynamics and therapeutic options. This innovative approach may ultimately enhance our ability to address AMD and similar conditions.

References

1. Ophthalmology Management, 2026 -- RPE Modeling May Advance AMD Research
2. Exudative (Wet) Age-Related Macular Degeneration (AMD) Guidelines: Guidelines Summary
3. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2 - PubMed
4. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials - ScienceDirect
5. Archives of Toxicology — Establishment of a 3D Human Gut Model for the Reconstructed Intestinal Micronucleus Cytome (RICyt) Assay to Evaluate Genotoxicity of Orally Administered Substances
6. Basic Research in Cardiology — The impact of transient outward K+ currents on electrical remodeling in the hearts of female rats following voluntary exercise
7. Retinal Physician — Surgical Technique Developed for Retinal Cell Therapy
8. Exudative (Wet) Age-Related Macular Degeneration (AMD) Guidelines: Guidelines Summary
9. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2 - PubMed
10. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials - ScienceDirect